End-Stage Kidney Disease

Finding that protein-energy wasting was prevalent in children with kidney disease, researchers outlined what they deemed to be the “most useful” methods for making accurate diagnoses of the condition in this patient population.

Patients hospitalized for COVID-19 with end-stage renal disease exhibited better outcomes than patients with non-dialysis chronic kidney disease, according to a study.

A conservative weight loss program was effective for a “small proportion” of kidney transplant candidates with obesity, namely those who had a lower BMI at baseline.

The United States Patent Office has issued a patent to Victor Gura, MD, FASN, for a wearable artificial kidney, and the nephrologist said he wants to begin a clinical trial later this year to test the third-generation device.

Incremental dialysis – up to 2 sessions a week – is an effective way to help patients transition into dialysis while still preserving residual renal function, a speaker said.

Research presented at the American Nephrology Nurses Association National Symposium revealed 14% of patients who chose conservative management went on to receive dialysis.

Patients who received in-center hemodialysis at facilities in New York City had similar seropositivity rates for SARS-CoV-2 infection as did residents of the same neighborhoods, study results showed.

In the first half of 2020, patients with end-stage kidney disease had a significant increase in all-cause mortality from previous years and a significantly higher hospitalization rate for COVID-19 than the general population, results show.

Blue Cross and Blue Shield of Minnesota announced it will partner with DaVita Inc. to launch its integrated kidney care VillageHealth program in the Blue Cross Minnesota network.

A national survey shows patients on dialysis who are hesitant about taking a vaccine for COVID-19 share similar characteristics to those in the general public with the same views, a speaker said.